Skip to content

GSK plc Price, Chart & Factor Exposure

Free Data & Analytics Access

Next earnings: Wed, Feb 3, 2027, after the market closes · estimates and history

GSK plc · E.GS71.XETRA · Germany
Use symbol E.GS71.XETRA in our API & Excel add-in to retrieve this data ↓
22.01
(+0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum -50%
Trend 0%
Bubble Risk LOW
Realised Volatility (20D) 28.83%

GSK plc Forecast

GSK plc short-term momentum is negative (up over 1 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is neutral (4 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term NEUTRAL signal. Based on 20-day realised volatility of 28.8% a year, a typical one-standard-deviation range is 21.12–22.90 over a week, 20.18–23.84 over a month and 15.66–28.36 over a year. (Signals as of 22 Nov 2026.)

GSK plc Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
GSK plc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
GSK plc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
GSK plc
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for GSK plc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on GSK plc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

GSK plc Trading Strategies

9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to GSK plc; 1 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

Explore all strategies →

Statistical Distribution of Returns

Plus

How GSK plc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how GSK plc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About GSK plc (Germany)

GSK plc is a listed security in Germany. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is GSK plc?
GSK plc is a listed security in Germany. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest GSK plc price?
The latest close is 22.01 (22 Nov 2026), +0.01% on the day. The price at the top of the page refreshes during the trading day.
Is GSK plc in an uptrend?
As of 22 Nov 2026, short-term momentum is negative (1 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is neutral (4 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is GSK plc?
20-day realised volatility is 28.8% a year (22 Nov 2026), which implies a typical one-standard-deviation move of about 8.3% over a month and 4.1% over a week.
What factors affect GSK plc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to GSK plc, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade GSK plc?
9 backtested tactical asset allocation strategies trade GSK plc through VGK; 1 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are GSK plc returns analysed?
The Statistical Distribution of Returns section shows the distribution of GSK plc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free GSK plc historical data?
In the Free historical data section of this page: the last 10 years of GSK plc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free GSK plc historical data (last 10 years)

Browse or instantly download the last 10 years of GSK plc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.GS71.XETRA&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2022.01
2026-11-1921.82
2026-11-1822.29
2026-11-1722.39
2026-11-1623.09
2026-11-1322.91
2026-11-1222.75
2026-11-1122.3364
2026-11-1022.6931
2026-11-0922.5742
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases; and strategic research collaboration with Engitix Ltd. to identify and validate novel therapeutic targets driving liver fibrosis regression. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.